| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 600.2 | 542.8 | 502.4 |
| Other income | 28.4 | 33.7 | 25.7 |
| Total income | 628.5 | 576.5 | 528.2 |
| Profit before exceptional items & tax | 213.4 | 203.9 | 176.6 |
| Exceptional items | 0.0 | -0.0 | 0.1 |
| Profit before tax | 213.4 | 203.9 | 176.7 |
| Net profit | 172.9 | 165.9 | 145.3 |
| Operating margin | 34.0% | 35.4% | 33.5% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +19.00% |
|---|---|
| Net profit, quarter on quarter | +4.20% |
| Revenue, year on year | +19.50% |
BSE results filing, NSE: CAPLIPOINT. Figures extracted from the filing.
Caplin Point Laboratories Ltd: key numbers
- Share price
- ₹2,835.10
- Market cap
- ₹21,550 Cr
- Revenue (annual)
- ₹2,187 Cr
- Net profit (annual)
- ₹641.2 Cr
- P/E (TTM)
- 32.4×Sector 50.4×
- Promoter holding
- 70.57%+0.00% QoQ
- FII holding
- 5.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Caplin Point Laboratories Ltd
All →Caplin Point Laboratories Annual General Meeting
Caplin Point Laboratories concluded its 35th Annual General Meeting on September 25, 2026. Key business included adopting financial statements and approving the final dividend declaration.
Caplin Point Laboratories Price Movement Clarification
Caplin Point Laboratories clarified that the recent increase in its stock's trading volume is market-driven. The company confirmed no undisclosed material information exists regarding this movement.
Caplin Point Laboratories Other Announcement
Caplin Point Laboratories Limited shared a weblink for its 35th AGM Notice and Annual Report for FY 2025-26. The communication targets shareholders with unregistered email addresses.
Caplin Point Laboratories Annual General Meeting
Caplin Point Laboratories Limited scheduled its 35th Annual General Meeting for September 25, 2026. Key agenda items include adopting financial statements and declaring a ₹4 final dividend.
Caplin Point Laboratories Annual Report
Caplin Point Laboratories Limited submitted its Annual Report for FY 2025-26. The company's 35th Annual General Meeting is scheduled for September 25, 2026.
Caplin Point Laboratories Price Movement Clarification
Caplin Point Laboratories has clarified that recent trading volume spikes are market-driven. The company confirms it has no undisclosed price-sensitive information.